Esteban Lopez Sells 250 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of the stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $93.00, for a total transaction of $23,250.00. Following the sale, the director owned 3,450 shares in the company, valued at approximately $320,850. This trade represents a 6.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Esteban Lopez also recently made the following trade(s):

• On Thursday, May 21st, Esteban Lopez sold 250 shares of Addus HomeCare stock. The stock was sold at an average price of $93.00, for a total transaction of $23,250.00.

Addus HomeCare Price Performance

ADUS opened at $92.65 on Friday. The firm has a market cap of $1.73 billion, a price-to-earnings ratio of 17.13, a price-to-earnings-growth ratio of 1.28 and a beta of 0.92. Addus HomeCare Corporation has a fifty-two week low of $89.76 and a fifty-two week high of $124.43. The company’s 50-day moving average price is $95.72 and its 200 day moving average price is $105.47. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. Addus HomeCare’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.42 earnings per share. As a group, sell-side analysts expect that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Stephens dropped their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Barclays dropped their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research note on Friday, May 15th. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Wednesday, February 25th. Finally, KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently made changes to their positions in the company. Global Retirement Partners LLC increased its stake in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare during the 4th quarter valued at about $29,000. Arax Advisory Partners increased its stake in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares during the period. Finally, Private Trust Co. NA increased its stake in Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.